Trillium Therapeutics Inc. logo

Trillium Therapeutics Inc.

Sector: 
Healthcare
   

Industry: 
Biotechnology

18.44
 
USD
  
0.00
  
(0.00%)
Optionable: Yes  Market Cap: 1,936 M  90-day average vol: 0

Previous close: 18.44  Open:   Bid:   Ask:
52 week range    
5.80   
   18.49
Peers   
Last updated: Friday 12th August 2022

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Chart
News
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com


Financials

TRIL Income Statement

Annual

Dec-11Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20
Total revenues00000000124000148000
Cost of sales-250352-6374-609323-566807-329858-3 M-4 M-2 M-609000-591000
Gross operating profit0-40000000124000148000
Selling Gen & administrative expense8397964687109036692 M2 M3 M3 M3 M6 M36 M
Research & development expense2 M6267883 M9 M13 M22 M30 M34 M27 M25 M
Operating income-3 M-1 M-4 M-11 M-15 M-25 M-33 M-36 M-32 M-61 M
floaterest income0000000000
floaterest expense0000000000
Other income net-992350159311-88394 M-2 M-4 M3 M-6 M202000
Pre-tax Income (EBT)-3 M-1 M-4 M-11 M-11 M-26 M-36 M-33 M-38 M-59 M
Income taxes00006847-3 M3180700028000102000
Net income from total operations-3 M-1 M-4 M-11 M-11 M-24 M-36 M-33 M-38 M-59 M
Minority floaterest0000000000
Total net income-3 M-1 M-4 M-11 M-11 M-24 M-36 M-33 M-38 M-59 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-3 M-1 M-4 M-11 M-11 M-24 M-36 M-33 M-38 M-59 M
Depreciation25035264156093235668073298583 M4 M2 M609000591000
Amortization238116150000000000
Operating income before depreciation (EBITDA)-3 M-1 M-3 M-10 M-10 M-23 M-32 M-30 M-32 M-61 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-49.95-18.09-3.1-2.64-1.6-3.02-3.67-2.35-1.65-0.7
Diluted EPS total-49.95-18.09-3.1-2.64-1.6-3.02-3.67-2.35-1.65-0.7
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!